Joko Widodo
In such a scenario, being early can still offer substantial advantages, such as securing preferential terms, building deep relationships, and potentially influencing the company’s early trajectory. Yet, this intense confluence of investor interest inevitably drives up competition, making early-stage entry not just competitive but often prohibitively expensive. This dynamic is precisely what the startup ecosystem is witnessing with increasing frequency at the seed and Series A stages. The number of unusually large rounds – often referred to as "jumbo" or "mega" rounds – at these foundational stages has been steadily creeping up in recent quarters, becoming particularly prominent in the initial weeks of this year, signalling a profound shift in early-stage financing.
To fully grasp the scale of this transformation, a look at recent data is illustrative. Historically, seed and Series A rounds were typically measured in the low single-digit millions, reflecting the nascent, high-risk nature of these ventures. However, Crunchbase data reveals a stark departure from this norm, tracking rounds of $100 million or more at these early stages over the past few years. While jumbo seed and Series A deals have existed for some time, their frequency truly surged around the peak of the market in 2021. Following a predictable dip during the subsequent market correction, this trend has reignited with remarkable vigor in 2024.
This year, these colossal early-stage rounds are not merely a statistical anomaly but a pronounced comeback. According to Crunchbase data, an astonishing proportion of seed and Series A investment in 2024 has flowed into rounds of $100 million or more. Over 40% of all capital deployed at these stages has been captured by these mega-deals. This figure is strikingly high and represents a significant reorientation of capital allocation within the early-stage ecosystem, especially when considering that such mega-rounds were virtually non-existent for the vast majority of startup investment history. This concentration of capital indicates a clear strategy by investors to place substantial bets on a select few companies right from the outset.
While the phenomenon of giant early-stage rounds is observable globally, it is notably more prevalent within the U.S. startup landscape. Crunchbase data indicates that for U.S. startups, an even greater share – over half of all seed and Series A funding this year – has gone to financings of $100 million and up. This suggests that the competitive intensity, the availability of deep-pocketed investors, and perhaps the sheer ambition of U.S.-based founders and their ventures, are contributing to an accelerated evolution of early-stage funding norms. The sheer scale of capital being deployed reflects a bullish outlook on specific sectors and a willingness to pay a premium for perceived market leaders.
Unsurprisingly, a substantial preponderance of these early-stage mega-rounds are funneling into artificial intelligence (AI) startups. This finding, which will likely surprise no one closely observing the current technological landscape, underscores AI’s transformative potential and the immense capital requirements needed to compete in this rapidly evolving field. Developing cutting-edge AI models, securing top-tier research talent, and acquiring the necessary computational infrastructure all demand significant upfront investment, making traditional modest early-stage rounds often insufficient.
The most striking example of this trend in 2024 is the colossal $480 million seed financing secured by Humans&. This AI lab, founded in September by a dream team of top researchers hailing from industry giants like Google, Anthropic, xAI, OpenAI, and Meta, aims to apply AI technology in ways centered "around people and their relationships with each other." Such a massive seed round, particularly at the company’s inception, reflects both the formidable pedigree of its founders and the profound belief in their ability to make a significant impact in the AI space. It also highlights the strategic imperative for investors to secure an early, substantial stake in what they believe could be the next generation of AI leaders.
Another notable recipient of significant early capital is Ricursive Intelligence, a frontier AI lab that recently announced a $300 million Series A round, valuing the company at an impressive $4 billion. This valuation at such an early stage further underscores the heated competition and investor appetite for companies at the forefront of AI innovation. Similarly, Merge Labs, a startup co-founded by Sam Altman (of OpenAI fame) and focused on brain-computer interfaces integrating with advanced AI, reportedly locked up a $252 million seed round, with OpenAI itself being a major backer. These examples illustrate a clear pattern: foundational AI research and ambitious AI applications are attracting unprecedented levels of early-stage investment.
Beyond the core AI development, the application of AI across various sectors is also drawing substantial early funding. Abu Dhabi-based Mal, an AI-powered Islamic digital banking platform, exemplifies this trend. The startup secured $230 million in its inaugural funding round this month, led by BlueFive Capital, signaling strong investor confidence in AI’s potential to revolutionize traditional industries, even in niche markets. Another significant fundraiser was Upscale AI, an AI networking infrastructure startup, which closed on $200 million in Series A financing last week. These diverse examples — from foundational AI labs to industry-specific applications and infrastructure — paint a clear picture of AI’s pervasive influence on early-stage investment patterns.
While the classic seed round, typically in the low single-digit millions, certainly hasn’t disappeared—for every supergiant seed deal, dozens of smaller ones still occur in a typical month—the stereotype of early-stage funding is undeniably evolving. The traditional image of a seed round as a small, risky bet on an unproven founder with little more than a compelling idea and a nascent prototype may need considerable updating. While such deals still happen and remain vital for fostering truly novel, out-of-the-box innovation, a growing share of early-stage funding appears to be gravitating towards very proven innovators, serial entrepreneurs, or teams with exceptional, previously established track records.
This shift from "quirky to qualified" has significant implications. Investors are increasingly de-risking their early bets by backing founders who have either successfully built and exited companies before, possess deep domain expertise, or come from highly reputable institutions with a clear vision and an immediate ability to attract top talent. These founders often arrive with more developed plans, a network of potential customers or partners, and a higher probability of scaling rapidly. The concentration of capital in their hands allows them to hit the ground running, outcompete smaller rivals, and capture market share at an accelerated pace.
Is this development a net positive or negative for the broader startup ecosystem? A compelling case can be made for both perspectives. On the positive side, these large early rounds enable ambitious projects, particularly in capital-intensive sectors like AI, to secure the resources needed to truly innovate and scale without constant fundraising distractions. It allows companies to attract world-class talent, invest heavily in R&D, and build robust infrastructure from day one. For investors, it’s a strategy to secure a larger piece of what they believe will be a future unicorn or decacorn, mitigating dilution risk and maximizing potential returns by front-loading their investment.
However, the downsides are equally significant. Such concentrated capital could potentially stifle genuine grassroots innovation, making it harder for truly novel but unproven founders to secure initial funding if they lack the "proven" pedigree. It raises the bar for entry, creating an increasingly exclusive club of well-connected or previously successful entrepreneurs who can command such large checks. These mega-rounds also come with increased pressure for rapid growth and monumental valuations, potentially leading to higher burn rates and less room for error or experimentation. For investors, while the potential rewards are high, the risks are also amplified; larger checks mean greater exposure to single companies, and inflated early valuations can lead to difficult down rounds or write-offs if performance doesn’t match expectations. It’s certainly gotten costlier for those writing the checks, demanding more rigorous due diligence and a stronger conviction in the chosen few.
Ultimately, the trend of giant seed and Series A rounds signifies a profound transformation in early-stage venture capital. It reflects a market where capital is abundant, competition for top-tier talent and ideas is fierce, and technological shifts, particularly in AI, are demanding unprecedented levels of early investment. While it creates incredible opportunities for a select group of well-funded startups to achieve scale at an unprecedented pace, it also redefines the landscape for aspiring entrepreneurs and challenges the traditional tenets of early-stage investing, forcing a re-evaluation of what it means to be "early" and "promising" in the modern startup world. The long-term implications for diversity, innovation, and market concentration will be critical to observe as this trend continues to unfold.
